Best of Astro 2017- Gastrointestinal
This session about Gastrointestinal Cancer will provide a review of the most highly rated abstracts in the GI track from the ASTRO 2017 Annual Meetings. This session will highlight results of technological advances and clinical research that will provide the attendees with knowledge to manage patients with the most up-to-date therapies. This session will crystallize the most important radiation oncology research and trends related to gastrointestinal cancer and aims to narrow professional practice gaps. This session will also provide information about recently published literature about Gastrointestinal Cancers that shapes the modern care of patients.
This meeting is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists and radiation oncology residents.
- Describe the results of recent clinical trials in Gastrointestinal Cancers, and determine the implication of these results to the attendee’s practice.
- Apply knowledge of radiotherapy delivery to guide patient care decisions in Gastrointestinal Cancers
- Identify prognostic factors for outcomes of radiation therapy in Gastrointestinal Cancers
- Salma Jabbour, Md is an Associate Profressor at Rutgers University. Dr. Jabbour receives research funding from Merck.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.